Cargando…
Serum Metabolomics Signatures Associated With Ankylosing Spondylitis and TNF Inhibitor Therapy
Ankylosing spondylitis (AS) is a type of spondyloarthropathies, the diagnosis of which is often delayed. The lack of early diagnosis tools often delays the institution of appropriate therapy. This study aimed to investigate the systemic metabolic shifts associated with AS and TNF inhibitors treatmen...
Autores principales: | Ou, Jiayong, Xiao, Min, Huang, Yefei, Tu, Liudan, Chen, Zena, Cao, Shuangyan, Wei, Qiujing, Gu, Jieruo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933516/ https://www.ncbi.nlm.nih.gov/pubmed/33679777 http://dx.doi.org/10.3389/fimmu.2021.630791 |
Ejemplares similares
-
Etanercept/celecoxib on improving MRI inflammation of active ankylosing spondylitis: A multicenter, open-label, randomized clinical trial
por: Tu, Liudan, et al.
Publicado: (2022) -
The Clinical Characteristics of Other HLA-B Types in Chinese Ankylosing Spondylitis Patients
por: Wu, Xinyu, et al.
Publicado: (2021) -
Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis
por: Chen, Zena, et al.
Publicado: (2021) -
Cost of Illness, Quality of Life, and Work Outcomes in Active Ankylosing Spondylitis Patients Treated With Adalimumab in China
por: Tu, Liudan, et al.
Publicado: (2020) -
Efficacy and safety of loxoprofen hydrogel patch versus loxoprofen tablet in patients with ankylosing spondylitis: A 4-week randomized, open-label study
por: Fan, Meida, et al.
Publicado: (2019)